Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Pharma Tech

Tarsus joins Stargardt race to market with $800m Alkeus takeover

Aug 7, 2026, 11:13 AM

Read Full Article → Tarsus joins Stargardt race to market with $800m Alkeus takeover

Tarsus joins Stargardt race to market with $800m Alkeus takeover

Translate article text

Choose a language and wait for the translated text.

Alongside Alkeus, companies like Belite Bio, Ocugen and Nanoscope are aiming to secure a place on the Stargardt market with no approved drugs.

Tarsus joins Stargardt race to market with $800m Alkeus takeover | PharmaVoice